You are in: eMedicine Specialties > Pediatrics: Cardiac Disease and Critical Care Medicine > Cardiothoracic Surgery Pulmonary Atresia With Ventricular Septal DefectArticle Last Updated: May 17, 2006AUTHOR AND EDITOR INFORMATIONAuthor: Edwin Rodriguez-Cruz, MD, Assistant Professor, Department of Pediatrics, San Juan Bautista Medical School and Medical Center; Consulting Interventional/Clinical Pediatric Cardiologist, Department of Prediatrics, Hospital El Maestro and San Juan Bautista Medical Center; Consulting Interventional/Clinical Pediatric Cardiologist, Department of Cardiology, Cardiovascular Center of Puerto Rico and the Caribbean and Veterans Affairs Hospital and Medical Center of Puerto Rico Edwin Rodriguez-Cruz is a member of the following medical societies: American College of Cardiology, American College of Physicians-American Society of Internal Medicine, American Heart Association, American Medical Association, American Society of Echocardiography, Puerto Rico Medical Association, Society of Cardiac Angiography and Interventions, and Society of Pediatric Echocardiography Coauthor(s): Sanjeev Aggarwal, MD, MBBS, Staff Physician, Department of Pediatrics, Children's Hospital of Michigan; Ralph E Delius, MD, Associate Professor, Department of Surgery, Wayne State University Editors: Jonah Odim, MD, PhD, MBA, Senior Medical Officer, Transplantation Immunology Branch, Division of Allergy, Immunology, and Transplantation, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine.com, Inc; Mary C Mancini, MD, PhD, Director of Cardiothoracic Transplantation, Professor, Department of Surgery, Louisiana State University Health Sciences Center; Daniel Rauch, MD, FAAP, Director, Pediatric Hospitalist Program, Associate Professor, Department of Pediatrics, New York University School of Medicine; Stuart Berger, MD, Professor of Pediatrics, Division of Cardiology, Medical College of Wisconsin; Chief of Pediatric Cardiology, Medical Director of Pediatric Heart Transplant Program, Medical Director of The Heart Center, Children's Hospital of Wisconsin Author and Editor Disclosure Synonyms and related keywords: pulmonary atresia with ventricular septal defect, PA-VSD, tetralogy of Fallot with pulmonary atresia, TOF, pseudotruncus, truncus arterious type 4 INTRODUCTIONPulmonary atresia with ventricular septal defect (PA-VSD) is a cyanotic congenital heart disease characterized by underdevelopment of the right ventricular (RV) outflow tract (ie, subpulmonary infundibulum) with atresia of the pulmonary valve, a large ventricular septal defect (VSD), and overriding of the aorta. In the past, this anomaly was termed pseudotruncus or truncus arterious type 4. PA-VSD demonstrates a wide spectrum of severity, depending on the degree of pulmonary artery development. Pathologically, PA-VSD is frequently considered the most severe end of the spectrum of tetralogy of Fallot (TOF), but controversy exists as to whether PA-VSD and TOF should be treated as 2 distinct entities. In patients with the standard type of TOF with pulmonary atresia, pulmonary arteries are usually normal in size with normal peripheral pulmonary arborization, which is unlike PA-VSD. In addition, systemic-to-pulmonary collateral vessels are not as well developed in patients with TOF with pulmonary atresia as they are in patients with PA-VSD. FrequencyThe best estimates of the relative frequency of PA-VSD are 2.5-3.4% of all congenital cardiac malformations. PA-VSD is slightly more prevalent in males than in females. EtiologyThe actual genetic cause of PA-VSD is unknown. An association with velocardiofacial syndrome and DiGeorge syndrome has been found. Children of patients with PA-VSD have a higher risk of having congenital heart lesions than children of parents without PA-VSD. PathophysiologyIn PA-VSD, the extent of pulmonary artery development determines the clinical presentation and the surgical options available. Pulmonary artery atresia may be local only, with involvement of the pulmonary valve and the proximal portion of the pulmonary trunk, or it may involve a longer segment. The right and left pulmonary arteries may communicate freely (ie, confluence) or may not communicate (ie, nonconfluence). Pulmonary circulation may be supplied by a patent ductus arteriosus (PDA), systemic-to-pulmonary collaterals, or plexuses of bronchial and pleural arteries. The pathology of intrapulmonary arteries depends on the pulmonary blood flow and the patency of the ductus. If the ductus is large and supplies confluent pulmonary arteries, the blood flow and the intrapulmonary arteries of both lungs are normal. If collaterals are multiple and the ductus is congenitally absent, abnormal intrapulmonary arborization (ie, stenosis of unbranched and intrapulmonary arteries) and pulmonary hypertension are present. Collateral arteries most commonly arise from the thoracic aorta and less commonly arise from subclavian arteries, internal mammary arteries, intercostal arteries, or the abdominal aorta. Rarely, the collateral arteries arise from coronary arteries. In 60% of patients, the collateral arteries are stenosed at the aortic end or at intrapulmonary sites, and stenosis tends to progress over time. The VSD may be membranous or infundibular, is usually very large, and rarely is obstructed by membranous tissue. In 50% of patients, a secundum-type atrial septal defect (ASD) or a patent foramen ovale (PFO) also is present. In 26-50% of patients, the aorta arises predominantly from the RV and a dilated right-sided aortic arch may be present. The RV and, to a lesser extent, the right atrium usually are moderately to markedly hypertrophied and dilated. The left atrium and left ventricle (LV) usually are normal. The coronary arteries usually are normal, although anomalies have been observed, such as a high origin of the coronary ostia, coronary artery–to–pulmonary artery fistulae, and transposition anatomy with the right coronary artery originating from the left anterior aortic sinus and transversing the right ventricular infundibulum. Other associations include tricuspid atresia or stenosis, complete atrioventricular (AV) canal, complete or corrected transposition of the great arteries, left superior vena cava, anomalies of the coronary sinus, dextrocardia, and asplenia or polysplenia syndrome. Classification
ClinicalThe age at presentation may vary depending on the amount of pulmonary blood flow. However, the great majority of patients present in the newborn period after the closure of the ductus arteriosus. If collateral vessels are well developed, presentation may be delayed, although rarely. The vast majority of patients present with cyanosis and hypoxia. Hypoxia usually is severe and is present when the entire pulmonary flow is reduced and a closing ductus arteriosus is the only source of pulmonary blood flow. If systemic collateral arteries are well developed or if the PDA is wide open, hypoxia is not severe in neonates. Patients may present with progressive hypoxia later because growth outstrips the pulmonary blood flow. On rare occasions, an infant with a large PDA or well-developed systemic collateral arteries may present at age 4-6 weeks with heart failure with increased pulmonary blood flow and minimal cyanosis. This heart failure may be very difficult to control medically. Paroxysms of dyspnea and squatting occasionally occur in older children. Hemoptysis may occur as a result of rupture of extensive systemic-to-pulmonary collateral arteries. Important and recurrent infections can occur because of immunodeficiency, especially if associated with DiGeorge syndrome. Survival to adulthood has been described in a few patients with well-developed collateral arteries. Growth and development are usually delayed secondary to cyanosis or congestive heart failure (CHF). Central (ie, perioral) cyanosis is usually mild at birth, but it becomes very severe with the closure of the PDA. Cyanosis may fluctuate for the first few days because the ductus arteriosus may constrict and relax intermittently. The patient may have anomalies of the face, palate, and ears as described in velocardiofacial syndrome. Peripheral pulses are usually normal in neonates and remain normal in cyanotic infants. In infants with wide-open PDAs, well-developed systemic collateral arteries, or surgically created shunts, pulses may become pronounced after 4-6 weeks because of a wide pulse pressure. Signs of heart failure are rare. Heart pulsation is most prominent at the left lower sternal border. Heart size is usually normal. A prominent a wave in the jugular pulse may be found. The following may be observed on auscultation:
Distinguishing characteristics for the diagnosis of PA-VSD can be divided into 2 major groups, as follows:
Consult a pediatric cardiologist, a pediatric cardiothoracic surgeon, and a geneticist. INDICATIONSCriteria for complete surgical repair are as follows:
CONTRAINDICATIONSContraindications for complete surgical repair include (1) hypoplastic or absent central pulmonary arteries and (2) inadequate peripheral arborization of pulmonary arteries. WORKUPLab Studies
Imaging Studies
Other Tests
Diagnostic Procedures
TREATMENTMedical therapyIn patients with a ductal-dependent circulation, prostaglandin E2 is often required to keep the ductus arteriosus open in the early neonatal period until surgery can be performed. A neonate who is ill may require fluid and acidosis management, but mechanical ventilation is rarely needed. Medical treatment with digitalis, diuretics, and other agents may be indicated in patients with CHF resulting from increased pulmonary blood flow. Phlebotomy to relieve the adverse effects of extreme polycythemia in very hypoxic patients is rarely performed. In patients with CHF and increased work of breathing, a high-energy diet is required. Rarely, a patient may require placement of a nasogastric tube to achieve the goals of energy intake. Surgical therapyVarious options are available, depending on the anatomy of the individual patient. Palliative surgery If the atresia is limited to the pulmonary valve (eg, imperforate pulmonary valve, membranous pulmonary atresia), the valve can be perforated percutaneously using special devices designed for this specific purpose, such as a needle or, more recently, a radiofrequency ablation catheter. Then, after the perforation is done, the valve is dilated with a balloon catheter. Stents can be placed in stenosed aortopulmonary collateral arteries in patients with hypoplastic pulmonary arteries. Palliative extracardiac systemic-to-pulmonary shunts can be placed to promote growth of pulmonary arteries. Direct aortopulmonary shunts (eg, Waterston shunt, Pott shunt) were used in the past but, subsequently, were found to create severe distortion, scarring, interruption of the pulmonary arteries, and, on occasion, pulmonary hypertension. Thus, the use of these shunts has fallen into disfavor. Currently, the modified Blalock-Taussig shunt is used most commonly and is connected from the subclavian or innominate artery to the pulmonary artery (when anatomy permits). In recent years, a direct right ventricle to pulmonary arteries shunt has been placed with good results. Valveless conduits or homografts may be used to connect the RV to the pulmonary artery. This may promote the growth of pulmonary arteries. In infants with CHF caused by excessive aortopulmonary collateral arteries, flow can be reduced by performing surgical interruption or by judicious banding or percutaneous coil occlusion of selected systemic arterial collaterals. Complete surgical repair The objective of complete repair is to create an unrestricted continuity between the RV outflow tract and the pulmonary arterial tree using nonvalved or valved conduits. Subsequently, all extracardiac sources of pulmonary blood flow need to be ligated. The ASDs and VSDs need to be closed. An important goal is to achieve a satisfactory ratio between the peak systolic pressures in the RV and the LV (RV/LV ratio). Various approaches have been devised to achieve a complete surgical repair, including the following:
Heart-lung transplantation In patients with completely atretic main, left, and right pulmonary arteries, heart-lung transplantation is a viable option. Complications of surgery include the following:
Follow-upCareful monitoring for drug dosing and adverse effects is necessary. Monitor patients for adequacy of repair and postoperative complications. Obtain echocardiograms on a regular basis, paying special attention to surgically created shunts, residual shunts, and the flow through RV outflow tract conduits. For excellent patient education resources, visit eMedicine's Heart Center. Also, see eMedicine's patient education articles Tetralogy of Fallot and Ventricular Septal Defect. COMPLICATIONSPossible complications include the following:
OUTCOME AND PROGNOSISPatients may require repeated surgeries for a complete repair. Educate family members regarding congenital heart disease and how to perform cardiopulmonary resuscitation (CPR). Genetic counseling for future pregnancies is necessary. MULTIMEDIA
REFERENCES
Pulmonary Atresia With Ventricular Septal Defect excerpt Article Last Updated: May 17, 2006 | |||||||||||||||||||||||||||||||||||